Amy E. Cyr, MD | Authors

PUBLIX PHARMACY #766

Articles

Molecular Profiling Assays in Breast Cancer: Beyond Prime Time and Into Syndication

April 17, 2012

Future randomized studies should focus on determining which patients benefit most from the inclusion of molecular diagnostics in treatment decision making and on the development of treatment algorithms that incorporate patient factors, histologic and biologic findings, and molecular markers.